Store-operated Orai3 calcium channels in metabolism and obesity
商店操纵的 Orai3 钙通道在代谢和肥胖中的作用
基本信息
- 批准号:10599319
- 负责人:
- 金额:$ 10.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdipocytesAmericanAreaAttenuatedBiological ProcessBlood PressureBlood VesselsBrainBrown FatCalciumCalcium ChannelCalcium SignalingCalcium-Sensing ReceptorsCardiovascular DiseasesCell NucleusCell membraneCell physiologyCellsCentral Nervous SystemComplexDataDeacetylationDevelopmentDietDiseaseDyslipidemiasElectron MicroscopyEpidemicFatty acid glycerol estersGene ExpressionGenerationsGenetic TranscriptionGlucose tolerance testGoalsGrowthHeart DiseasesHeart failureHigh Fat DietHomeostasisHouse miceHyperglycemiaHypertensionInsulin ResistanceKnock-outKnockout MiceKnowledgeLabelLifeLipolysisMalignant NeoplasmsMammalsMeasuresMediatingMedicalMembrane PotentialsMetabolicMetabolic DiseasesMetabolismMethodsMitochondriaModalityMolecularMusNerveNeuronsNon-Insulin-Dependent Diabetes MellitusNorepinephrineObese MiceObesityObesity associated cardiovascular diseaseObesity associated diseaseOrganellesOverweightOxidative PhosphorylationOxidoreductasePPAR gammaPathologyPathway interactionsPeripheral Nervous SystemPersonsPhenotypePhysiologicalPhysiologyPlayPopulationPredispositionProtein IsoformsProteinsRNARabies virusRegulationResearchRisk FactorsRoleRouteSLC17A8 geneSecond Messenger SystemsSignal PathwaySignaling MoleculeSpinalStructureSympathetic GangliaTelemetryTestingThermogenesisTissuesTransgenic MiceVertebral columnWeight GainWorkcancer typecardiometabolismcell typeexperimental studyheart functioninsulin tolerancelipid metabolismmitochondrial metabolismnerve supplyneuronal excitabilitynovelobesity treatmentreceptor couplingspatiotemporaltranscription factoruncoupling protein 1
项目摘要
Project Summary/Abstract
This K99/R00 proposal aims to characterize novel molecular mechanisms of obesity and
develop non-invasive methods for treating obesity and obesity-related cardiovascular diseases. The
proposal addresses a fundamental gap in knowledge with a significant impact on the treatment of
obesity. Obesity is a major contributor to several pathologies, including type 2 diabetes, cardiovascular
disease, and cancer. In recent years, studies have shown that Ca2+ signals play a crucial role in lipid
metabolism. Orai proteins (Orai1-3) are highly Ca2+ selective channels that contribute ubiquitous and
evolutionary conserved routes of regulated Ca2+ entry into all cells and play a major role in a myriad of
cellular and physiological functions, including lipolysis. Here, I propose to study the function of Ca2+
entry through Orai3, a mammalian specific Ca2+ selective Orai channel protein, in metabolism, neuronal
innervation, neuronal activation, and its role in regulating thermogenesis and obesity. We have
generated Orai3 whole-body knockout and Orai3flx/flx mice for tissue-specific knockouts. My preliminary
data show that Orai3 knockout mice housed at 15-18°C and on regular diets quickly become obese,
and their weight gain is derived from fat accumulation. This suggests that Orai3 plays an essential role
in fat metabolism. These Orai3 KO mice also have reduced heat generation, reduced sympathetic
innervation to brown adipose tissue (BAT), suggesting that adiposity is due to reduced BAT
thermogenesis and/or altered innervation or activation of norepinephrine (NE) producing sympathetic
neurons, which regulate BAT thermogenesis. In this application, I propose to address the above-
described causes of adiposity in Orai3 KO mice with the following three aims and key experiments, 1)
Ca2+ entry through Orai3 is crucial for BAT mitochondrial heat generation to control adiposity, which
will be determined by measuring parameters of mitochondrial metabolism. 2) Orai3 activity is critical for
Ca2+-dependent gene transcription of UCP1, required for BAT thermogenesis, which will be assessed
by studying the transcription factors that regulate UCP1 expression and by rescuing UCP1 expression
in Orai3 KO mice and determining cardio-metabolism on Orai3 KO and UCP1-rescued mice. 3) Orai3
is required in the central and peripheral nervous system (CNS and PNS) to regulate BAT activity, which
will be determined by analyzing Orai3 levels in both CNS and PNS using RNA scope, deleting Orai3 in
CNS and measuring BAT activity, and deleting Orai3 in CNS and measuring cold and high fat diet-
induced hypertension and obesity. This study will help decipher the unique role of Orai3 in BAT and in
both central and sympathetic neurons. It will bridge the gap between Ca2+ homeostasis and
mitochondrial function and unveil a novel role for Orai3 Ca2+ signaling in lipid metabolism and obesity,
establishing Orai3 as a target in obesity and obesity-related cardiovascular disease.
项目概要/摘要
该 K99/R00 提案旨在表征肥胖和肥胖的新分子机制
开发治疗肥胖和肥胖相关心血管疾病的非侵入性方法。
提案解决了知识上的根本差距,对治疗产生重大影响
肥胖是导致多种疾病的主要原因,包括 2 型糖尿病、心血管疾病。
近年来,研究表明Ca2+信号在脂质中起着至关重要的作用。
Orai 蛋白 (Orai1-3) 是高度 Ca2+ 选择性通道,有助于无处不在的代谢。
受调节的 Ca2+ 进入所有细胞的进化保守途径,并在无数细胞中发挥重要作用
细胞和生理功能,包括脂肪分解在这里,我建议研究Ca2+的功能。
通过 Orai3(一种哺乳动物特异性 Ca2+ 选择性 Orai 通道蛋白)进入代谢、神经元
神经支配、神经激活及其在调节产热和肥胖中的作用。
生成了 Orai3 全身敲除小鼠和用于组织特异性敲除的 Orai3flx/flx 小鼠。
数据显示,Orai3 基因敲除小鼠在 15-18°C 的环境下饲养并定期饮食,很快就会变得肥胖,
他们的体重增加来自于脂肪积累,这表明Orai3起着至关重要的作用。
这些 Orai3 KO 小鼠的热量产生也减少,交感神经减少。
棕色脂肪组织 (BAT) 的神经支配,表明肥胖是由于 BAT 减少所致
生热作用和/或神经支配改变或去甲肾上腺素 (NE) 产生交感神经的激活
调节 BAT 生热作用的神经元 在本申请中,我建议解决上述问题。
描述了 Orai3 KO 小鼠肥胖的原因,具有以下三个目标和关键实验,1)
Ca2+ 通过 Orai3 进入对于 BAT 线粒体产热以控制肥胖至关重要,这
2) Orai3 活性对于
BAT 生热作用所需的 UCP1 Ca2+ 依赖性基因转录,将对其进行评估
通过研究调节 UCP1 表达的转录因子并挽救 UCP1 表达
在 Orai3 KO 小鼠中,并确定 Orai3 KO 和 UCP1 拯救小鼠的心脏代谢 3) Orai3。
中枢和周围神经系统(CNS 和 PNS)需要调节 BAT 活性,
将通过使用RNA范围分析CNS和PNS中的Orai3水平来确定,删除Orai3
CNS并测量BAT活性,并删除CNS中的Orai3并测量冷和高脂肪饮食-
这项研究将有助于破译 Orai3 在 BAT 和 BAT 中的独特作用。
它将弥合 Ca2+ 稳态和交感神经元之间的差距。
线粒体功能并揭示了 Orai3 Ca2+ 信号在脂质代谢和肥胖中的新作用,
将 Orai3 确定为肥胖和肥胖相关心血管疾病的靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Trayambak Pathak其他文献
Trayambak Pathak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Trayambak Pathak', 18)}}的其他基金
Store-operated Orai3 calcium channels in metabolism and obesity
商店操纵的 Orai3 钙通道在代谢和肥胖中的作用
- 批准号:
10427729 - 财政年份:2022
- 资助金额:
$ 10.45万 - 项目类别:
相似国自然基金
骨骼肌来源的GDF15介导铁死亡调控脂肪细胞代谢重编程在线粒体病中的机制研究
- 批准号:82301590
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成脂调节蛋白ADIRF上调KROX20/KLF4通道诱导异体脂肪脱细胞基质体内成脂的机制研究
- 批准号:82372544
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肝细胞源MIF招募CD74+胰腺癌细胞介导非酒精性脂肪肝(NAFLD)驱动的胰腺癌肝转移的机制研究
- 批准号:82303933
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
- 批准号:82300966
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
CD36/FABP4/CPT1轴介导脂肪酸转运促进白血病干细胞的维持在白血病化疗耐药中的作用及机制研究
- 批准号:82300206
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms Driving Enhanced Susceptibility of Females versus Males to High-Fat Diet-Induced Increases in High Blood Pressure
女性与男性相比,对高脂肪饮食引起的高血压的易感性增强的机制
- 批准号:
10714531 - 财政年份:2023
- 资助金额:
$ 10.45万 - 项目类别:
Elucidating extragonadal functions of follicle stimulating hormone using genetic approaches in mice
利用小鼠遗传方法阐明促卵泡激素的性腺外功能
- 批准号:
10685473 - 财政年份:2022
- 资助金额:
$ 10.45万 - 项目类别:
Discovery and characterization of a novel acylcarnitine transporter in brown adipocytes
棕色脂肪细胞中新型酰基肉碱转运蛋白的发现和表征
- 批准号:
10681400 - 财政年份:2022
- 资助金额:
$ 10.45万 - 项目类别:
Store-operated Orai3 calcium channels in metabolism and obesity
商店操纵的 Orai3 钙通道在代谢和肥胖中的作用
- 批准号:
10427729 - 财政年份:2022
- 资助金额:
$ 10.45万 - 项目类别:
Validation of ALDH1A1 as a target for the treatment of obesity: effects of ALDH1A1 inhibition on energy metabolism
验证 ALDH1A1 作为肥胖治疗靶点:抑制 ALDH1A1 对能量代谢的影响
- 批准号:
10443471 - 财政年份:2022
- 资助金额:
$ 10.45万 - 项目类别: